Case–control study of HLA-G promoter methylation status, HPV infection and cervical neoplasia in Curitiba, Brazil: a pilot analysis
Authors:
- Anna Gillio-TosAGAnna Gillio-Tos
- Maria da Graça BicalhoMBMaria da Graça Bicalho
- Valentina FianoVFValentina Fiano
- Chiara GrassoCGChiara Grasso
- Valentina TaralloVTValentina Tarallo
- Laura De MarcoLMLaura De Marco
- Morena TrevisanMTMorena Trevisan
- MarinaBarbaradeSousa XavierMXMarinaBarbaradeSousa Xavier
- Renata SlowikRSRenata Slowik
- Newton S CarvalhoNCNewton S Carvalho
- Carlos A MaestriCMCarlos A Maestri
- Hadriano M LacerdaHLHadriano M Lacerda
Open Access
- 24 December 2012
- journal article
- Published by Springer Nature in BMC Cancer
- Vol. 12 (1) , 618
Abstract
The causal association between persistent human papillomavirus (HPV) infection and cervical cancer has been established, but the mechanisms that favor HPV persistence in cervical cells are still unknown. The diminished capability of the immune system to control and resolve HPV infection is one of several hypotheses. The tolerogenic protein HLA-G has shown aberrant expression in a variety of cancers, which has been suggested as a mechanism for tumor escape from immunosurveillance. In the present study we evaluate the role of epigenetic modification (promoter de-methylation) of the HLA-G gene on susceptibility to HPV infection and development of high-grade cervical lesions.Keywords
This publication has 72 references indexed in Scilit:
- Ethnic Differences in DNA Methyltransferases Expression in Patients with Systemic Lupus ErythematosusJournal of Clinical Immunology, 2012
- Brazilian urban population genetic structure reveals a high degree of admixtureEuropean Journal of Human Genetics, 2011
- CpG islands and the regulation of transcriptionGenes & Development, 2011
- Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?Cellular and Molecular Life Sciences, 2010
- HLA-G: a human pregnancy-related immunomodulatorCurrent Opinion in Pharmacology, 2009
- A review of human carcinogens—Part B: biological agentsThe Lancet Oncology, 2009
- Utility of methylation markers in cervical cancer early detection: Appraisal of the state-of-the-scienceGynecologic Oncology, 2009
- Epigenetic changes within the promoter region of the HLA-G gene in ovarian tumorsMolecular Cancer, 2008
- Viral oncoproteins target the DNA methyltransferasesOncogene, 2006
- Natural History of Cervical Intraepithelial NeoplasiaInternational Journal of Gynecological Pathology, 1993